Prospective Evaluation of the Relation Between Different Questionnaires Measuring Radiation-induced Side-effect
NCT ID: NCT06295783
Last Updated: 2026-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
300 participants
OBSERVATIONAL
2024-06-10
2027-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perceptions of Side Effects of Cancer Chemoradiotherapy
NCT02978846
New Assessment System in Measuring Symptom Distress in Cancer Patients
NCT00505245
Symptoms Experienced and Quality of Life in Breast Cancer Receiving Radiotherapy
NCT03106350
Nurse Intervention Project
NCT01091584
Sexual Health Counseling Intervention During Radiation Therapy in Improving Quality of Life for Women With Gynecologic Cancer
NCT04269837
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
• To investigate how different toxicity questionnaires with different scoring systems can be reliably translated to each other by estimating different measures of correlation between items and summary scores across different questionnaires.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Head and Neck Cancer (HNC) Questionnaire
Participants will be asked to fill out three head and neck cancer (HNC) questionnaires during your visits to the clinic:
1. The MDASI-HN questionnaire (standard-of-care) has 28 questions.
2. The EORTC QLQ-HN35 questionnaire has 35 questions.
3. The EORTC QLQ-30 questionnaire has 30 questions.
MDASI-HN
Given by Questionnaire
EORTC QLQ-C30
Given by Questionnaire
EORTC HN35
Given by Questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MDASI-HN
Given by Questionnaire
EORTC QLQ-C30
Given by Questionnaire
EORTC HN35
Given by Questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English as a primary language
* Participants with a diagnosis of HNC undergoing active curative RT or having received curative RT within the past 5 years at MD Anderson
* Ability to complete the survey(s) of their own volition
Exclusion Criteria
* Non-English speaking participants
* Participants who are receiving or have received RT in a non-HN site.
* Participants in follow up and over 5 years from post-treatment
* Neurocognitive deficits that render patients unable to complete the survey(s) on their own.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amy Moreno, MD
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MD Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
MD Anderson Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2024-01955
Identifier Type: OTHER
Identifier Source: secondary_id
2023-1059
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.